• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者的代谢综合征:病因及病理生理后果

Metabolic syndrome in patients with COPD: Causes and pathophysiological consequences.

作者信息

Fekete Monika, Szollosi Gergo, Tarantini Stefano, Lehoczki Andrea, Nemeth Anna N, Bodola Csenge, Varga Luca, Varga Janos Tamas

机构信息

1 Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

2 Department of Family and Occupational Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.

出版信息

Physiol Int. 2022 Mar 3. doi: 10.1556/2060.2022.00164.

DOI:10.1556/2060.2022.00164
PMID:35238797
Abstract

BACKGROUND

Decreased physical activity significantly increases the probability of prevalent metabolic syndrome (MetS) with substantial impact on the expected course of COPD.

OBJECTIVE

Our research aims to assess the metabolic consequences of chronic obstructive pulmonary disease (COPD) and evaluate the prevalence of MetS and its interrelations with age, sex, comorbidities, drug intake, degree of decreased lung function, nutritional status, physical activity and quality of life.

METHODS

A cross-sectional study was performed on a random sample (n = 401) at the Department of Pulmonary Rehabilitation of the National Koranyi Institute of Pulmonology from March 1, 2019 to March 1, 2020 in Budapest, Hungary. Anthropometric and respiratory function tests and laboratory parameters of all patients were registered.

RESULTS

MetS occurred in 59.1% of COPD patients with significant gender difference (male: 49.7% female: 67.6%). Concerning BMI, the prevalence of MetS was higher with BMI≥25 kg m-2 (P < 0.0001). Patients with this syndrome had significantly worse FEV1%pred (43 (30-56) vs. 47 (36-61); P = 0.028), lower quality of life (CAT: 26 (21-32) vs. 24.5 (19-29); P = 0.049) and significantly more frequent exacerbations (2 (1-3) vs.1 (0-2); P < 0.05), than patients without MetS. The prevalence of comorbidities were higher in overweight/obese patients (BMI> 25 kg m-2).

CONCLUSIONS

In COPD patients MetS negatively affect respiratory function and quality of life and promotes exacerbations of the disease. MetS is related to nutritional status and the level of systemic inflammation in COPD patients.

摘要

背景

身体活动减少会显著增加患代谢综合征(MetS)的概率,对慢性阻塞性肺疾病(COPD)的预期病程有重大影响。

目的

我们的研究旨在评估慢性阻塞性肺疾病(COPD)的代谢后果,评估代谢综合征(MetS)的患病率及其与年龄、性别、合并症、药物摄入、肺功能下降程度、营养状况、身体活动和生活质量的相互关系。

方法

2019年3月1日至2020年3月1日在匈牙利布达佩斯国家科兰伊肺科研究所肺康复科对一个随机样本(n = 401)进行了横断面研究。记录了所有患者的人体测量和呼吸功能测试以及实验室参数。

结果

59.1%的COPD患者发生了MetS,存在显著的性别差异(男性:49.7%;女性:67.6%)。关于体重指数(BMI),BMI≥25 kg/m²时MetS的患病率更高(P < 0.0001)。患有该综合征的患者的预计第一秒用力呼气容积百分比(FEV1%pred)显著更差(43(30 - 56)对47(36 - 61);P = 0.028),生活质量更低(COPD评估测试(CAT):26(21 - 32)对24.5(19 - 29);P = 0.049),且急性加重明显更频繁(2(1 - 3)对1(0 - 2);P < 0.05),比无MetS的患者。超重/肥胖患者(BMI>25 kg/m²)的合并症患病率更高。

结论

在COPD患者中,MetS对呼吸功能和生活质量产生负面影响,并促进疾病的急性加重。MetS与COPD患者的营养状况和全身炎症水平有关。

相似文献

1
Metabolic syndrome in patients with COPD: Causes and pathophysiological consequences.慢性阻塞性肺疾病患者的代谢综合征:病因及病理生理后果
Physiol Int. 2022 Mar 3. doi: 10.1556/2060.2022.00164.
2
[Metabolic consequences of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病的代谢后果]
Orv Hetil. 2021 Jan 31;162(5):185-191. doi: 10.1556/650.2021.31984.
3
[Clinical value of omega-3 polyunsaturated fatty acid supplementation in chronic obstructive pulmonary disease].[补充ω-3多不饱和脂肪酸在慢性阻塞性肺疾病中的临床价值]
Orv Hetil. 2021 Jan 3;162(1):23-30. doi: 10.1556/650.2021.31973.
4
Effects of omega-3 supplementation on quality of life, nutritional status, inflammatory parameters, lipid profile, exercise tolerance and inhaled medications in chronic obstructive pulmonary disease.ω-3 补充剂对慢性阻塞性肺疾病患者生活质量、营养状况、炎症参数、血脂谱、运动耐量和吸入药物的影响。
Ann Palliat Med. 2022 Sep;11(9):2819-2829. doi: 10.21037/apm-22-254. Epub 2022 Aug 2.
5
[Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].[体重指数及胸部CT特征在慢性阻塞性肺疾病评估中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020 Feb 28;42(1):55-61. doi: 10.3881/j.issn.1000-503X.11206.
6
Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study.代谢综合征在慢性阻塞性肺疾病患者中的流行情况、相关因素及临床后果:一项为期 5 年的前瞻性观察研究。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167342. doi: 10.1177/17534666231167342.
7
Impact of comorbidities in COPD clinical control criteria. The CLAVE study.COPD 临床控制标准中合并症的影响。CLAVE 研究。
BMC Pulm Med. 2024 Jan 2;24(1):6. doi: 10.1186/s12890-023-02758-0.
8
COPD patients with and without metabolic syndrome: clinical and functional differences.患有和未患有代谢综合征的慢性阻塞性肺疾病患者:临床和功能差异
Intern Emerg Med. 2014 Jun;9(4):419-25. doi: 10.1007/s11739-013-0945-7. Epub 2013 May 5.
9
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease: An observational study in South Indians.慢性阻塞性肺疾病患者代谢综合征的患病率:一项在印度南部人群中的观察性研究。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):503-507. doi: 10.1016/j.dsx.2020.04.042. Epub 2020 May 4.
10
Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation.慢性阻塞性肺疾病患者的代谢综合征:发生率及其与全身炎症的关系
Hippokratia. 2016 Apr-Jun;20(2):110-114.

引用本文的文献

1
Establishment and validation of a nomogram for predicting acute exacerbation of chronic obstructive pulmonary disease based on the C-reactive protein-triglyceride-glucose index.基于C反应蛋白-甘油三酯-葡萄糖指数的慢性阻塞性肺疾病急性加重预测列线图的建立与验证
Medicine (Baltimore). 2025 Sep 5;104(36):e42754. doi: 10.1097/MD.0000000000042754.
2
Prevalence and clinical characteristics of fibromyalgia syndrome in individuals with chronic obstructive pulmonary disease: A cross-sectional study.慢性阻塞性肺疾病患者中纤维肌痛综合征的患病率及临床特征:一项横断面研究。
J Int Med Res. 2025 Aug;53(8):3000605251368253. doi: 10.1177/03000605251368253. Epub 2025 Aug 25.
3
The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis.
慢性阻塞性肺疾病中代谢综合征的患病率:一项系统评价和荟萃分析。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251346194. doi: 10.1177/14799731251346194. Epub 2025 May 26.
4
Metabolic syndrome, small airway dysfunction and the mediating role of inflammation.代谢综合征、小气道功能障碍及炎症的中介作用
Sci Rep. 2025 Apr 12;15(1):12555. doi: 10.1038/s41598-025-97326-3.
5
Therapeutic Management in Patients with Chronic Obstructive Pulmonary Disease Who Are Overweight or Obese: A Systematic Review and Meta-Analysis.超重或肥胖的慢性阻塞性肺疾病患者的治疗管理:一项系统评价和荟萃分析。
J Clin Med. 2025 Feb 13;14(4):1230. doi: 10.3390/jcm14041230.
6
The Role of Trace Elements in COPD: Pathogenetic Mechanisms and Therapeutic Potential of Zinc, Iron, Magnesium, Selenium, Manganese, Copper, and Calcium.微量元素在慢性阻塞性肺疾病中的作用:锌、铁、镁、硒、锰、铜和钙的发病机制及治疗潜力
Nutrients. 2024 Nov 28;16(23):4118. doi: 10.3390/nu16234118.
7
Association of life's essential 8 with chronic obstructive pulmonary disease: a population-based analysis of NHANES 2007-2018.生命必需 8 项与慢性阻塞性肺疾病的关联:基于 NHANES 2007-2018 的人群分析。
BMC Public Health. 2024 Nov 13;24(1):3144. doi: 10.1186/s12889-024-20534-5.
8
Assessment of Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A 6-Month Follow-Up Study.慢性阻塞性肺疾病患者代谢综合征的评估:一项为期6个月的随访研究。
Diagnostics (Basel). 2024 Oct 31;14(21):2437. doi: 10.3390/diagnostics14212437.
9
The Possible Role of Food and Diet in the Quality of Life in Patients with COPD-A State-of-the-Art Review.食物和饮食在 COPD 患者生活质量中的可能作用——最新综述。
Nutrients. 2023 Sep 7;15(18):3902. doi: 10.3390/nu15183902.
10
Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures.暴露组学与非健康老龄化:从空气污染到职业暴露的环境驱动因素。
Geroscience. 2023 Dec;45(6):3381-3408. doi: 10.1007/s11357-023-00913-3. Epub 2023 Sep 9.